Fecal Immunochemical Testing for Colorectal Cancer and Medication Restrictions

Gastrointestinal Endoscopy - United States
doi 10.1016/j.gie.2017.01.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Fecal Immunochemical Testing: A Sensitive and Sustainable Approach for Population Colorectal Cancer Screening?

Gastroenterology
HepatologyGastroenterology
2016English

Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening

International Journal of Cancer
Cancer ResearchOncology
2018English

Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer

American Journal of Gastroenterology
HepatologyGastroenterology
2020English

Fecal Immunochemical Test-Based Colorectal Cancer Screening: The Gender Dilemma

United European Gastroenterology Journal
OncologyGastroenterology
2016English

Performance Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomatous Polyps

Annals of Internal Medicine
Internal MedicineMedicine
2019English

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Gastrointestinal Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2017English

Single Dose Aspirin Prior to Fecal Immunochemical Testing Does Not Increase Sensitivity for Advanced Colorectal Neoplasia

Gastroenterology
HepatologyGastroenterology
2019English

Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2015English

Clinical Impact of the Immunochemical Fecal Occult Blood Test for Colorectal Cancer Screening in Brazil

Annals of Gastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy